{"id":"W4378782417","doi":"10.1093/jnci/djad096","title":"Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting","year":2023,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; University of Texas MD Anderson Cancer Center; Weill Cornell Medical College; Genentech; National Institutes of Health; Ipsen; Peter MacCallum Cancer Centre; Yale University; University of Toronto; Vanderbilt University; Advanced Accelerator Applications; Roswell Park Cancer Institute; Ipsen Biopharmaceuticals; Vanderbilt University Medical Center; Cedars-Sinai Medical Center; Huntsman Cancer Institute; Exelixis; Memorial Sloan-Kettering Cancer Center; Johns Hopkins University; ECOG-ACRIN Cancer Research Group; Ohio State University; Temple University; Moffitt Cancer Center; University of Miami; AstraZeneca; University of Pennsylvania; Intermountain Healthcare; American College of Radiology Imaging Network; Leidos; School of Medicine, Boston University","keywords":"Clinical trial; Cancer; Medicine; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09132708,0.002101678,0.003210701,0.003428516,0.004282732,0.009175772,0.007353463,0.02383854,0.02698102],"category_scores_gemma":[0.08107607,0.001913718,0.00606408,0.003587517,0.001387474,0.004535907,0.007574025,0.02130249,0.01573178],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01531388,"about_ca_system_score_gemma":0.07620742,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01205507,"about_ca_topic_score_gemma":0.02443202,"domain_scores_codex":[0.9521416,0.02171971,0.005825961,0.002988498,0.01317898,0.004145369],"domain_scores_gemma":[0.8794692,0.02059743,0.01044792,0.003013385,0.0597294,0.02674254],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000180196,0.00007271439,0.00044789,0.0009690502,0.00007674284,0.0001401509,0.00006311279,0.0004242429,0.0002436748,0.001326406,0.965864,0.03019177],"study_design_scores_gemma":[0.0002876587,0.0001124005,0.001523614,0.002946024,0.0001187711,0.000212672,0.0001243973,0.0004083625,0.0002588021,0.002868989,0.991076,0.00006229499],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.001455995,0.0272628,0.01316084,0.7713315,0.09930407,0.009077776,0.01541472,0.0004258957,0.0625663],"genre_scores_gemma":[0.01339939,0.03694766,0.05392444,0.6469287,0.06092369,0.03005563,0.03847187,0.0008103349,0.1185384],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.09132708,"threshold_uncertainty_score":0.4829895,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3221195761151226,"score_gpt":0.5391666763430338,"score_spread":0.2170471002279112,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}